A virus that infects your brain, makes you want to bite things and is almost always fatal after symptoms appear probably sounds like something from a zombie movie. However, this has been the modus operandi of rabies at least since 2300 BC, when it was described in the Eshuma Code of Babylon. The word’s Sanskrit etymology — rabhas, meaning “to do violence” — dates back even further, to 3000 BC.
In principle, no human in this day and age should die from rabies, and yet, according to a study last year, the virus kills 59,000 people annually. That is 160 people every day and the actual number might be far higher if we could count unreported or untreated cases. Most of these deaths occur in Asia and Africa, with India alone accounting for one-third of the world’s total mortality from rabies.
That total is not as high as the death toll from tuberculosis, HIV/AIDS and malaria; but, unlike those diseases, every mammal appears to be susceptible to rabies. Dogs, the predominant host in most regions, can become infected from any rabid wild animal and then infect humans. Dogs showing symptoms might bite a human, but they can also transmit the virus simply by licking if their saliva comes into contact with a scratch, damaged skin or mucosa.
The rabies virus hijacks the nervous system and actually manipulates neural processes to make its host move faster. Infected humans will eventually hallucinate, become aggressive and even fear water in the advanced stages of the disease.
Once these symptoms appear, rabies has no known cure and death is almost certain. Fortunately, unlike most vaccine-preventable diseases, rabies allows for post-exposure inoculation, because the time of infection is generally known by the victim — especially if they were bitten — and the disease’s incubation period is relatively long, ranging from days to years, but averaging three to eight weeks. Whether administered before or after exposure, the vaccine is the same, but the immunization schedule and the dosage differ between the two scenarios.
French scientist Louis Pasteur formulated the first rabies vaccine in 1885, by injecting the virus into rabbits, waiting for it to kill them and then drying the infected nerve tissues to weaken the virus to the point that it could be safely administered. Then he successfully tested it on a nine-year-old boy who had been bitten by a rabid dog.
In today’s world, Pasteur would be thrown in jail for practicing as an unlicensed physician and not following proper clinical-practice standards, but we can all be thankful for his discovery.
Today, rabies vaccines are grown in a lab using cell cultures. The virus is then rendered inactive, purified and administered by injection into the arm. The WHO recommends pre-exposure vaccinations for anyone whose occupation or residence implies continual, frequent or increased risk of encountering rabies. This applies to everyone in rabies-endemic countries; unfortunately, not everyone in these countries gets vaccinated.
The rabies vaccine is on the WHO List of Essential Medicines and has an average wholesale price of US$11 per dose in the developing world, and as much as US$250 per dose in the US. Of course, because the alternative to post-exposure vaccination is death, the treatment is extremely cost-effective however one looks at it.
Smallpox, which is believed to have emerged even before rabies, has now been eradicated, and programs are currently under way to put an end to polio, Guinea worm disease and other infectious ailments. So why is rabies still prevalent?
One reason is that the virus is almost always transmitted by animals, rather than by other humans. To address this, we should be investing in pet vaccinations, reducing wild and stray-animal populations, and enforcing strict quarantines on animals crossing national borders.
In developed countries, preventing rabies largely requires controlling and immunizing wildlife populations, which has proved effective in Switzerland and Germany. In Latin American countries, where bat rabies is a threat, bovine vaccines have been used, as have anticoagulants, to kill bats that feed off the blood of the treated cattle.
Ultimately, the world’s poorest regions still bear most of the rabies burden. Dogs are not widely vaccinated, as they are in developed countries; and even when they are, their populations turn over very rapidly. Within a year of a large-scale vaccination effort, a new population of unvaccinated dogs will be roaming the streets and increasing the chances of an outbreak.
Meanwhile, developing countries’ healthcare systems are already grappling with tuberculosis, HIV/AIDS and malaria; and post-exposure prophylaxis supplies are limited.
Barring real progress on these challenges, one of the world’s oldest known viruses will continue to afflict humans and animals alike.
Melvin Sanicas, a public health physician and vaccinologist, is regional medical expert at Sanofi Pasteur, Asia, Japan and the Pacific.
Copyright: Project Syndicate
Saudi Arabian largesse is flooding Egypt’s cultural scene, but the reception is mixed. Some welcome new “cooperation” between two regional powerhouses, while others fear a hostile takeover by Riyadh. In Cairo, historically the cultural capital of the Arab world, Egyptian Minister of Culture Nevine al-Kilany recently hosted Saudi Arabian General Entertainment Authority chairman Turki al-Sheikh. The deep-pocketed al-Sheikh has emerged as a Medici-like patron for Egypt’s cultural elite, courted by Cairo’s top talent to produce a slew of forthcoming films. A new three-way agreement between al-Sheikh, Kilany and United Media Services — a multi-media conglomerate linked to state intelligence that owns much of
The US and other countries should take concrete steps to confront the threats from Beijing to avoid war, US Representative Mario Diaz-Balart said in an interview with Voice of America on March 13. The US should use “every diplomatic economic tool at our disposal to treat China as what it is... to avoid war,” Diaz-Balart said. Giving an example of what the US could do, he said that it has to be more aggressive in its military sales to Taiwan. Actions by cross-party US lawmakers in the past few years such as meeting with Taiwanese officials in Washington and Taipei, and
Denmark’s “one China” policy more and more resembles Beijing’s “one China” principle. At least, this is how things appear. In recent interactions with the Danish state, such as applying for residency permits, a Taiwanese’s nationality would be listed as “China.” That designation occurs for a Taiwanese student coming to Denmark or a Danish citizen arriving in Denmark with, for example, their Taiwanese partner. Details of this were published on Sunday in an article in the Danish daily Berlingske written by Alexander Sjoberg and Tobias Reinwald. The pretext for this new practice is that Denmark does not recognize Taiwan as a state under
The Republic of China (ROC) on Taiwan has no official diplomatic allies in the EU. With the exception of the Vatican, it has no official allies in Europe at all. This does not prevent the ROC — Taiwan — from having close relations with EU member states and other European countries. The exact nature of the relationship does bear revisiting, if only to clarify what is a very complicated and sensitive idea, the details of which leave considerable room for misunderstanding, misrepresentation and disagreement. Only this week, President Tsai Ing-wen (蔡英文) received members of the European Parliament’s Delegation for Relations